Bupropion
Brand names: Wellbutrin, Wellbutrin XL, Zyban
Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)Key Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
⚠ FDA Black Box Warning
Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. Bupropion is not approved for use in pediatric patients.
Serious neuropsychiatric events have been reported in patients taking bupropion for smoking cessation. These events have included changes in behavior, hostility, agitation, depression, suicidal thoughts and behavior, and attempted suicide. Observe patients for the occurrence of such symptoms and instruct them to discontinue bupropion and contact a healthcare provider if they experience such adverse events.
Emergency Information
Poison Control: 1-800-222-1222
How does Bupropion work?
Bupropion works differently from most antidepressants. While SSRIs target serotonin and SNRIs target serotonin and norepinephrine, bupropion primarily affects two other neurotransmitters: dopamine and norepinephrine. For this reason, it is classified as a norepinephrine-dopamine reuptake inhibitor (NDRI) [1, 2, 4].
Bupropion blocks the reuptake of dopamine and norepinephrine at nerve terminals, increasing their availability in the synaptic cleft [1, 5, 14]. Dopamine is the neurotransmitter most closely associated with motivation, pleasure, reward, and concentration. Norepinephrine is involved in alertness, energy, and attention. By boosting both, bupropion helps address the low motivation, fatigue, and concentration difficulties that are common in depression [1, 5].
Because bupropion does not significantly affect serotonin, it avoids the side effects most commonly associated with serotonergic antidepressants — namely sexual dysfunction (decreased libido, delayed orgasm, erectile dysfunction) and weight gain [7]. This makes bupropion uniquely positioned among antidepressants for patients who are sensitive to these side effects [7, 10].
For smoking cessation (marketed as Zyban), bupropion's mechanism is believed to involve its effects on dopamine and norepinephrine in the brain's reward pathway [3, 6]. Nicotine stimulates dopamine release; by providing an alternative source of dopamine enhancement, bupropion reduces nicotine cravings and withdrawal symptoms. It may also act as a non-competitive antagonist at nicotinic acetylcholine receptors [1, 3, 14].
Bupropion is available in three formulations: immediate-release (IR, taken 3 times daily), sustained-release (SR, taken twice daily), and extended-release (XL, taken once daily). The active metabolite hydroxybupropion has a longer half-life and contributes significantly to the drug's clinical effects [1, 2, 5].
What to expect when starting Bupropion
When you start bupropion for depression, most doctors prescribe the XL (extended-release) formulation, starting at 150 mg once daily for the first week, then increasing to 300 mg once daily [1, 2]. This gradual start helps minimize initial side effects and reduces seizure risk.
Common initial side effects include dry mouth, insomnia, headache, nausea, and restlessness [1, 2]. Unlike most other antidepressants, bupropion tends to be activating rather than sedating — it often increases energy and alertness. For this reason, it is best taken in the morning (or early afternoon for twice-daily SR dosing) to avoid insomnia [1, 2].
Meaningful improvement in depression symptoms typically takes 2-4 weeks, with full benefit at 6-8 weeks [1, 10]. Some patients notice increased energy and motivation before mood fully improves.
A notable advantage of bupropion: it typically does not cause sexual side effects (decreased libido, delayed orgasm, erectile dysfunction) and may actually improve sexual function in some patients [7]. It is also weight-neutral to slightly weight-reducing, unlike many other antidepressants [1, 7, 10].
For smoking cessation (Zyban), treatment is typically started 1-2 weeks before the planned quit date to allow the drug to reach therapeutic levels in the brain [3, 6, 15].
The most important safety concern is seizure risk. The risk is dose-dependent and is approximately 0.1% at doses up to 300 mg/day [1, 2]. The risk increases sharply at doses above 450 mg/day. Do not crush, chew, or break extended-release tablets, as this can release the entire dose at once [1, 2].
What are the common side effects of Bupropion?
Common
- Insomnia11-20%
- Dry mouth17-26%
- Headache25-34%
- Nausea9-13%
- Dizziness6-11%
- Constipation8-10%
- Agitation/restlessness3-9%
- Tremor2-6%
- Increased sweating5-6%
- Decreased appetite/weight loss5-14%
- Tachycardia (rapid heart rate)3-11%
- Pharyngitis/sore throat3-11%
What are the serious side effects of Bupropion?
Serious
- Seizures0.1% at doses ≤300 mg/day; ~0.4% at 400 mg/day; risk increases sharply above 450 mg/day
- Suicidal thoughts and behavior (in young adults)Increased risk in patients under 25; see boxed warning
- Neuropsychiatric events (with smoking cessation)Uncommon; includes agitation, hostility, depression, suicidal ideation
- HypertensionClinically significant elevation in 6% of patients in some studies
- Psychosis and mania<1%; higher risk in patients with bipolar disorder
- Severe allergic reactions (anaphylaxis, Stevens-Johnson syndrome, angioedema)Very rare
- Angle-closure glaucomaVery rare
What drugs interact with Bupropion?
- MajorMAO inhibitors (selegiline, phenelzine) — CONTRAINDICATED. Do not use bupropion concurrently with MAOIs or within 14 days of discontinuing an MAOI. Increased risk of hypertensive crisis. Allow at least 14 days after stopping bupropion before starting an MAOI.
- MajorDrugs that lower seizure threshold (tramadol, theophylline, systemic steroids, antipsychotics) — Concurrent use of drugs that lower the seizure threshold increases the risk of bupropion-associated seizures. Use with extreme caution and at the lowest effective dose.
- ModerateCYP2D6 substrates (metoprolol, codeine, tamoxifen, desipramine) — Bupropion is a strong CYP2D6 inhibitor. It can significantly increase blood levels of CYP2D6 substrates. Desipramine AUC increased 5-fold with bupropion. For tamoxifen (a prodrug requiring CYP2D6 activation), bupropion may reduce efficacy — this combination should be avoided in breast cancer patients.
- ModerateCYP2B6 inhibitors (ticlopidine, clopidogrel) — CYP2B6 inhibitors can increase bupropion levels. Ticlopidine increased bupropion Cmax by 85% and AUC by 38%. Monitor for bupropion toxicity. Dose reduction may be needed.
- ModerateCYP2B6 inducers (rifampin, carbamazepine, phenytoin) — CYP2B6 inducers can substantially reduce bupropion levels. Rifampin may reduce bupropion levels by up to 90%. Higher bupropion doses may be needed, but do not exceed 450 mg/day.
- ModerateDopaminergic drugs (levodopa, amantadine) — Concurrent use may increase the risk of CNS adverse effects including agitation, restlessness, tremor, and psychosis due to additive dopaminergic stimulation.
- ModerateSSRIs (fluoxetine, paroxetine, sertraline) — Bupropion is commonly combined with SSRIs to augment antidepressant effect or counteract SSRI-induced sexual side effects. However, SSRIs metabolized by CYP2D6 (fluoxetine, paroxetine) may have levels increased by bupropion. Monitor for adverse effects.
- MinorNicotine replacement therapy (patches, gum) — Bupropion (Zyban) can be used with nicotine replacement therapy for smoking cessation. The combination is generally safe and may improve quit rates. Monitor blood pressure, as both can increase it modestly.
Can I eat certain foods or drink alcohol with Bupropion?
Alcohol should be minimized or avoided while taking bupropion. Alcohol lowers the seizure threshold, and combining it with bupropion increases seizure risk [1, 2, 3]. Additionally, if you normally consume alcohol regularly and then stop abruptly while on bupropion, alcohol withdrawal can further increase seizure risk. The prescribing information recommends minimizing or avoiding alcohol [1, 2].
Bupropion can be taken with or without food. Taking it with food does not significantly affect absorption [1, 2].
Do NOT crush, break, or chew sustained-release (SR) or extended-release (XL) tablets. This can release the entire dose at once, increasing the risk of seizures and other adverse effects [1, 2].
There are no significant food interactions that affect bupropion's effectiveness [1]. However, the CYP2B6 enzyme system that metabolizes bupropion can be affected by certain medications — always inform your doctor of all medications you take [1, 2, 5].
What is the typical dosage for Bupropion?
Major depressive disorder [1, 2]: - XL formulation: Start 150 mg once daily in the morning for 3-4 days, then increase to 300 mg once daily. Maximum: 450 mg once daily - SR formulation: Start 150 mg once daily in the morning for 3 days, then 150 mg twice daily (at least 8 hours apart). Maximum: 200 mg twice daily (400 mg/day) - IR formulation: Start 100 mg twice daily, increase to 100 mg three times daily (at least 6 hours apart) after 3 days. Maximum: 150 mg three times daily (450 mg/day)
Seasonal affective disorder (XL only) [2]: - Start 150 mg once daily in autumn (before symptoms begin) - May increase to 300 mg once daily after 1 week if needed - Continue through winter; taper to 150 mg/day for 2 weeks before stopping in spring
Smoking cessation (Zyban SR) [3, 6, 15]: - Start 150 mg once daily for 3 days, then 150 mg twice daily (at least 8 hours apart) - Begin 1-2 weeks before planned quit date - Continue for 7-12 weeks; extended treatment up to 6 months may reduce relapse
Available forms [1, 2, 3]: IR tablets: 75, 100 mg; SR tablets: 100, 150, 200 mg; XL tablets: 150, 300, 450 mg
Critical [1, 2]: Do NOT exceed 450 mg/day. No single dose should exceed 150 mg (IR), 200 mg (SR), or 450 mg (XL). Seizure risk is strongly dose-dependent.
Hepatic impairment [1, 2]: Reduce dose and frequency. Severe: max 75 mg/day (IR), 100 mg/day or 150 mg QOD (SR), 150 mg QOD (XL) Renal impairment [1]: Consider dose reduction; metabolites accumulate
How much does Bupropion cost?
Generic bupropion is widely available and affordable in all three formulations (IR, SR, XL) [12].
Generic bupropion XL 300 mg (30 tablets) typically costs $10-$25 with a discount coupon. Brand-name Wellbutrin XL can cost $1,500+ without insurance [12]. Generic bupropion SR 150 mg typically costs $8-$20 for 60 tablets.
Most insurance plans cover generic bupropion with minimal copays ($5-$20). Prior authorization is rarely required [12].
Generic Zyban (bupropion SR 150 mg for smoking cessation) is often available at the same low cost as generic bupropion SR for depression — it is the same drug at the same dose [3, 12].
Some state Medicaid programs and private insurers cover smoking cessation medications (including bupropion/Zyban) with no copay under ACA preventive services requirements [12].
GSK (manufacturer of Wellbutrin and Zyban) offers patient assistance programs for eligible uninsured patients [12]. In 2012, the FDA confirmed that one specific generic bupropion XL 300 mg product was not bioequivalent and required its withdrawal — all currently marketed generics meet FDA standards [11].
Is Bupropion safe during pregnancy or breastfeeding?
Pregnancy: Bupropion is not assigned a specific FDA pregnancy category under current labeling [1, 2]. Data from pregnancy registries have not shown a consistent increase in major malformations. Some studies suggested a possible small increase in cardiovascular malformations (specifically left outflow tract defects), but this has not been confirmed across all studies [1, 2].
For smoking cessation during pregnancy, bupropion may be considered when behavioral interventions alone fail, as smoking itself carries significant risks to the fetus [3]. The decision to use bupropion during pregnancy should balance untreated maternal depression/smoking risks against potential fetal risks [1, 2, 13].
Breastfeeding: Bupropion and its metabolites are excreted in breast milk. The relative infant dose of bupropion is estimated at approximately 2% of the weight-adjusted maternal dose [1, 13]. One case report described a seizure in a breastfed infant exposed to bupropion. While this is an isolated report, the risk warrants consideration. Monitor the infant for irritability, seizures, and poor feeding [1, 13].
Is there a generic version of Bupropion?
Generic bupropion is available from numerous manufacturers in all three formulations (IR, SR, XL). All generic versions are rated therapeutically equivalent by the FDA [9, 11].
In 2012, the FDA confirmed that a specific generic bupropion XL 300 mg product (manufactured by Impax/Amneal) was not bioequivalent to brand-name Wellbutrin XL and required its withdrawal [11]. This was an isolated case — all currently marketed generics have met FDA bioequivalence standards.
If you experience a change in effectiveness or new side effects after switching between generic manufacturers, discuss it with your pharmacist and doctor. The pharmacist may be able to order consistently from one manufacturer [11].
Brand-name Wellbutrin and Wellbutrin XL are rarely dispensed today. Virtually all prescriptions are filled with generic versions at a fraction of the brand cost [9, 12].
For Caregivers
If you care for someone taking bupropion, be aware of the seizure risk. Ensure they do not exceed the prescribed dose, do not crush or chew extended-release tablets, and minimize alcohol use [1, 2]. Know the signs of a seizure (sudden loss of consciousness, uncontrolled movements, staring spells) and how to respond.
For patients under 25, monitor for suicidal thoughts and behavior as required by the FDA boxed warning [8]. This is especially important during the first few months and after dose changes. Report worsening depression, unusual behavior changes, or suicidal statements to the prescriber immediately.
For smoking cessation patients, monitor for neuropsychiatric symptoms: changes in behavior, hostility, agitation, depression, and suicidal ideation [3, 15]. These can occur during treatment and after stopping.
Ensure the person takes bupropion early in the day to minimize insomnia. If insomnia persists and is severe, notify the prescriber [1, 2].
Do not allow the patient to take bupropion with other bupropion-containing products (e.g., Wellbutrin and Zyban simultaneously), as this can lead to doses above the seizure threshold [1, 2, 3].
Frequently asked questions about Bupropion
References
- [Regulatory] Wellbutrin (bupropion hydrochloride) tablets prescribing information. GlaxoSmithKline. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018644s054lbl.pdf Accessed 2025-01-15.
- [Regulatory] Wellbutrin XL (bupropion hydrochloride extended-release tablets) prescribing information. Bausch Health. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021515s039lbl.pdf Accessed 2025-01-15.
- [Regulatory] Zyban (bupropion hydrochloride sustained-release tablets) prescribing information. GlaxoSmithKline. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020711s040lbl.pdf Accessed 2025-01-15.
- [Regulatory] Bupropion hydrochloride. National Library of Medicine DailyMed drug label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c87f4f0b-cf2a-4c1e-b23d-a4e3132ae0a2 Accessed 2025-01-15.
- [Regulatory] Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clin Ther. 2005;27(11):1685-1695. https://pubmed.ncbi.nlm.nih.gov/15564893/ Accessed 2025-01-15.
- [Regulatory] Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340(9):685-691. https://pubmed.ncbi.nlm.nih.gov/9116280/ Accessed 2025-01-15.
- [Regulatory] Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry. 2006;67(5):736-746. https://pubmed.ncbi.nlm.nih.gov/16651466/ Accessed 2025-01-15.
- [Regulatory] FDA: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications Accessed 2025-01-15.
- [Regulatory] Drugs@FDA: FDA-Approved Drugs — Wellbutrin NDA 018644. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018644 Accessed 2025-01-15.
- [Regulatory] Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder. Lancet. 2018;391(10128):1357-1366. https://pubmed.ncbi.nlm.nih.gov/24005186/ Accessed 2025-01-15.
- [Regulatory] FDA: Evaluation of Certain Bupropion Hydrochloride Extended-Release Products (generic bioequivalence update). https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-approved-and-generic-bupropion-hydrochloride-extended-release-tablets Accessed 2025-01-15.
- [Observational] GoodRx. Bupropion Prices, Coupons & Savings Tips. https://www.goodrx.com/bupropion Accessed 2025-01-15.
- [Regulatory] UpToDate. Bupropion: Drug information. Wolters Kluwer. https://www.uptodate.com/contents/bupropion-drug-information Accessed 2025-01-15.
- [Clinical] Huecker MR, Siddiqui J, Parsa P. Bupropion. StatPearls. NCBI Bookshelf. https://pubmed.ncbi.nlm.nih.gov/25002308/ Accessed 2025-01-15.
- [Regulatory] Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES). Lancet. 2016;387(10037):2507-2520. https://pubmed.ncbi.nlm.nih.gov/26058451/ Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: